This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Fresnillo | 3,626.0 | 5.2% |
| Next | 14,195.0 | 5.0% |
| AstraZeneca | 14,056.0 | 4.9% |
| Burberry Group | 1,364.0 | 4.6% |
| GSK | 1,896.0 | 4.3% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| JD Sports Fashion | 83.1 | -4.4% |
| Barratt Redrow | 375.9 | -2.8% |
| Pershing Square Holdings | 4,724.0 | -2.5% |
| Auto Trader Group | 576.2 | -2.0% |
| Berkeley Group Holdings | 3,914.0 | -2.0% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 10,123 | 1.2% | 22.8% |
| DOW JONES INDUS. AVG | 49,462 | 1.0% | 16.3% |
| DAX INDEX | 24,892 | 0.1% | 22.4% |
| NIKKEI 225 | 51,962 | 1.1% | 29.6% |
| S&P/ASX 200 INDEX | 8,696 | 0.2% | 5.0% |
| Commodity | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 56.25 | 1.54% |
| Brent Crude (ICE) | USD/bbl. | 60.02 | 1.14% |
| Gold Spot | USD/t oz. | 4,457 | 0.8% |
| Copper (Comex) | USd/lb. | 599 | 1.3% |
Click graph to enlarge
The UK 100 is called to open -14 points at 10,108. The UK 100 looks set to open slightly lower this morning, taking a breath from the momontus start the index has made to 2026.
The weaker performance comes amid a downturn for Asia markets after the Nikkei 225 and Hang Seng index both fell by more than 1% this morning.
The S&P and Dow Jones reached new heights on Tuesday as investors moved past the recent U.S. attack on Venezuela. The broad market index rose 0.62%, notching a record close of 6,944.82. It also posted a new all-time high during the session. The blue-chip Dow advanced 484.90 points, or 0.99%, likewise reaching an intraday all-time high and closing at a record of 49,462.08. The Nasdaq climbed 0.65% and ended at 23,547.17.
“Magnificent Seven” member Amazon lifted the three major averages, rising more than 3%. Other stocks related to artificial intelligence also supported the broader market, including Micron Technology and Palantir Technologies. Micron advanced around 10%, while Palantir climbed more than 3%.
GSK today announced EC approval for Shingrix prefilled syringe for shingles. Separately, Bepirovirsen positive Phase III trials is a potential treatment for Chronic Hepatitis B.
Reckitt Benckiser this morning proposed a special dividend of 235p in return of £1.6bn excess capital from divestment of Essential Home business.
Topps Tiles today reported a fifth consecutive quarter of like-for-like sales growth, which it said helped to mitigate the continued cost inflationary environment. Revenues in the Topps Tiles brand grew by 2% on an underlying basis, supported by a continued strong performance in its trade channel following growth of 3.7%.
UK
None
US
None
UK
Greggs (GRG) – Trading Announcement
Marks & Spencer (MKS) – Trading Announcement
US
None
German Retail Sales
German Unemployment
EU Harmonized Index of Consumer Prices
US ADP Employment Change
US Factory Orders
US ISM Services PMI
US JOLTS Job Openings
UK 100 companies going ex-dividend on 8th January 2026:
Sage Group
Ashtead Group
Experian
UK 250 companies going ex-dividend on 8th January 2026:
Workspace Group
XPS Pensions Group
TBC Bank Group
Greencore Group
MITIE Group
QintetiQ Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.